These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 32346029)
1. In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens. Blasco L; Ambroa A; Trastoy R; Bleriot I; Moscoso M; Fernández-Garcia L; Perez-Nadales E; Fernández-Cuenca F; Torre-Cisneros J; Oteo-Iglesias J; Oliver A; Canton R; Kidd T; Navarro F; Miró E; Pascual A; Bou G; Martínez-Martínez L; Tomas M Sci Rep; 2020 Apr; 10(1):7163. PubMed ID: 32346029 [TBL] [Abstract][Full Text] [Related]
2. Chen T; Xu W; Yu K; Zeng W; Xu C; Cao J; Zhou T Microb Drug Resist; 2021 Mar; 27(3):401-409. PubMed ID: 32721272 [No Abstract] [Full Text] [Related]
3. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Doymaz MZ; Karaaslan E Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061 [No Abstract] [Full Text] [Related]
4. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains. Havenga B; Ndlovu T; Clements T; Reyneke B; Waso M; Khan W BMC Microbiol; 2019 Dec; 19(1):303. PubMed ID: 31870288 [TBL] [Abstract][Full Text] [Related]
5. Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae. Vázquez-Ucha JC; Martínez-Guitián M; Lasarte-Monterrubio C; Conde-Pérez K; Arca-Suárez J; Álvarez-Fraga L; Pérez A; Crecente-Campo J; Alonso MJ; Bou G; Poza M; Beceiro A Biomed Pharmacother; 2020 Oct; 130():110606. PubMed ID: 32795924 [TBL] [Abstract][Full Text] [Related]
6. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa. Mikhail S; Singh NB; Kebriaei R; Rice SA; Stamper KC; Castanheira M; Rybak MJ Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182535 [TBL] [Abstract][Full Text] [Related]
8. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415 [TBL] [Abstract][Full Text] [Related]
9. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. Personne Y; Curtis MA; Wareham DW; Waite RD J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey. Ece G; Samlioglu P; Atalay S; Kose S Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089 [TBL] [Abstract][Full Text] [Related]
12. A Novel Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of In vitro Efficacy of Meropenem/Colistin and Meropenem/Fosfomycin Combinations on Multidrug Resistant Gram-Negative Bacilli]. Adaleti R; Nakipoğlu Y; Arıcı N; Kansak N; Çalık Ş; Şenbayrak S; Balık R; Aksaray S Mikrobiyol Bul; 2023 Jul; 57(3):365-377. PubMed ID: 37462301 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078 [TBL] [Abstract][Full Text] [Related]
17. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens. Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934 [TBL] [Abstract][Full Text] [Related]
18. Combined effect of SAR-endolysin LysKpV475 with polymyxin B and Gontijo M; Pereira Teles M; Martins Correia H; Pérez Jorge G; Rodrigues Santos Goes IC; Fasabi Flores AJ; Braz M; de Moraes Ceseti L; Zonzini Ramos P; Rosa E Silva I; Pereira Vidigal PM; Kobarg J; Miguez Couñago R; Alvarez-Martinez CE; Pereira C; Freire CSR; Almeida A; Brocchi M Microbiology (Reading); 2024 May; 170(5):. PubMed ID: 38739436 [TBL] [Abstract][Full Text] [Related]
19. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010 [No Abstract] [Full Text] [Related]
20. Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens. Antonelli A; Coppi M; Tellapragada C; Hasan B; Maruri A; Gijón D; Morecchiato F; de Vogel C; Verbon A; van Wamel W; Kragh KN; Frimodt-Møller N; Cantón R; Giske CG; Rossolini GM Int J Antimicrob Agents; 2022 Oct; 60(4):106668. PubMed ID: 36038097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]